Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2020)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Interest & Investment Income of $12649.0 in Q2 2020, down 87.6% quarter-over-quarter from $101993.0 in Q1 2020, and down 97.18% on a YoY basis from $448717.0 in Q3 2019.
Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2020) Analysis & Trends
Corbus Pharmaceuticals Holdings' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $12649.0 for Q2 2020.
- In Q2 2020, Interest & Investment Income fell 97.18% year-over-year to $12649.0; the TTM figure through Jun 2020 stood at $558973.0 (down 56.88% YoY), while the FY2019 annual figure was $1.2 million, up 24.92% from the prior year.
- Interest & Investment Income was $12649.0 for Q2 2020 at Corbus Pharmaceuticals Holdings, down from $101993.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $448717.0 in Q2 2019 to a low of -$5360.0 in Q1 2016.
- Historically, Interest & Investment Income has averaged $147564.4 across 5 years, with a median of $133073.0 in 2017.
- The sharpest annual moves came in 2016 and 2018: Interest & Investment Income tumbled 1057.14% in 2016, then surged 14791.73% in 2018.
- A 5-year view of Interest & Investment Income shows it stood at $1731.0 in 2016, then soared by 7587.64% to $133073.0 in 2017, then surged by 83.9% to $244725.0 in 2018, then slumped by 38.1% to $151477.0 in 2019, then plunged by 91.65% to $12649.0 in 2020.
- The last three Interest & Investment Income figures came in at $12649.0 (Q2 2020), $101993.0 (Q1 2020), and $151477.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 12,649.00 |
| Mar 31, 2020 | 101,993.00 |
| Dec 31, 2019 | 151,477.00 |
| Sep 30, 2019 | 292,854.00 |
| Jun 30, 2019 | 448,717.00 |
| Mar 31, 2019 | 334,595.00 |
| Dec 31, 2018 | 244,725.00 |
| Sep 30, 2018 | 268,335.00 |
| Jun 30, 2018 | 266,297.00 |
| Mar 31, 2018 | 203,421.00 |
| Dec 31, 2017 | 133,073.00 |
| Sep 30, 2017 | 43,402.00 |
| Jun 30, 2017 | 5,271.00 |
| Mar 31, 2017 | 1,366.00 |
| Sep 30, 2016 | 1,731.00 |
| Jun 30, 2016 | 4,049.00 |
| Mar 31, 2016 | -5,360.00 |
| Dec 31, 2015 | 2,644.00 |
| Sep 30, 2015 | 1,037.00 |
| Jun 30, 2015 | 155.00 |